Advanced Proteome Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of a new technology platform that is intended for the chemical modification of protein therapeutics. The firm's technology is applicable to the rapid growth areas of therapeutics and diagnostics, Protein Drugs, and Personalized Medicine, respectively, and is being applied to cancer therapeutics in the field of antibody-drug conjugates. The company was founded by Alexander Krantz on December 12, 2005 and is headquartered in Burnaby, Canada.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company